Evidence map›Paper›PMID 38610011›Full record

ArticleBMC women's health2024

"In our community, we normalize pain": discussions around menstruation and uterine fibroids with Black women and Latinas.

Minerva Orellana, Karen N DSouza, Jane Q Yap, Abhirami Sriganeshan, M Elena Jones, Charis Johnson, Megan Allyse, Sateria Venable, Elizabeth A Stewart, Felicity Enders and 1 more

Abstract read
In one paragraph

Article in BMC women's health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Minerva OrellanaDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Karen N DSouzaCenter for Clinical and Translational Science, Mayo Clinic, Rochester, MN, USA.
Jane Q YapDepartment of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Abhirami SriganeshanUniversity of Miami, Miami, FL, USA.
M Elena JonesDepartment of Neurology, Washington University School of Medicine, 4488 Forest Park, St. Louis, MO, 63108, USA.
Charis JohnsonDepartment of Neurology, Washington University School of Medicine, 4488 Forest Park, St. Louis, MO, 63108, USA.
Megan AllyseDepartment of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Sateria VenableThe Fibroid Foundation, Bethesda, MD, USA.
Elizabeth A StewartDivision of Reproductive Endocrinology, Department of Obstetrics & Gynecology, Mayo Clinic, Rochester, MN, USA.
Felicity EndersDepartment of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Joyce E Balls-BerryDepartment of Neurology, Washington University School of Medicine, 4488 Forest Park, St. Louis, MO, 63108, USA. j.balls-berry@wustl.edu.

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
NRSA Training CoreTL1TR002380 · NCATS · MAYO CLINIC ROCHESTER · PI Felicity T. B. Enders, ANTHONY John WINDEBANK · 2017 to 2026
$6.0M
NCATS NIH HHS TL1 TR002380NCATS NIH HHS UL1 TR002345
6 · The paper itself

Abstract

backgroundUterine fibroids are non-cancerous neoplasms that arise from the uterus affecting over 75% of women. However, there is a disparity with Black women having an increased prevalence of nearly 80%. Black women also experience increased symptom burden, including younger age at the time of diagnosis and increased number and volume of fibroids. Less is known about other ethnoracially diverse women such as Latinas and the potential cultural impacts on fibroid burden and treatment.

methodsCommunity engagement studios were conducted to facilitate discussions with stakeholders on their uterine fibroid and menstruation experience. We recruited Black women (n = 6) diagnosed with uterine fibroids and Latinas (n = 7) without uterine fibroids. We held two virtual community engagement studios split by uterine fibroid diagnosis. The studios were not audio recorded and notes were taken by four notetakers. The notes were thematically analyzed in Atlas.ti using content analysis.

resultsParticipants felt there was a lack of discussion around menstruation overall, whether in the home or school settings. This lack of menstruation education was pronounced when participants had their first menstruation experience, with many unaware of what to expect. This silence around menstruation led to a normalization of painful menstruation symptoms. When it came to different treatment options for uterine fibroids, some women wanted to explore alternative treatments but were dismissed by their healthcare providers. Many participants advocated for having discussions with their healthcare provider about life goals to discuss different treatment options for their uterine fibroids.

conclusionDespite uterine fibroid diagnosis, there is silence around menstruation. Menstruation is a normal biological occurrence and needs to be discussed to help prevent delayed diagnosis of uterine fibroids and possibly other gynecological disorders. Along with increased discussions around menstruation, further discussion is needed between healthcare providers and uterine fibroid patients to explore appropriate treatment options.

Indexed as

LeiomyomaMenstruationBlack or African AmericanBlack PeopleDysmenorrheaFemaleHispanic or LatinoHumansBlack womenCommunity-engaged researchHealth disparitiesLatinasLeiomyomasMenstruationTabooUterine fibroidsWomen’s health

Identifiers

PMID38610011
PMCPMC11010402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.